As David L. Carr-Locke, MD, sees it, the identification of a previously unknown anatomical structure in the human body harkens back to the medical discoveries of centuries past.

The primary goal of the study is to see whether adding radiation therapy to an intensive chemotherapy regimen will improve the survival rate of patients with borderline resectable pancreatic cancer.

Education is a major focus of Aaron Schulman, MD, an endocrinologist in the Division of Endocrinology, Diabetes, and Metabolism and Director of the Endocrinology Fellowship Program at NewYork-Presbyterian/Weill Cornell.

Laura C. Alonso, MD, a noted physician-scientist, has been appointed Chief of the Division of Endocrinology, Diabetes and Metabolism at NYP/WCMC and Director of the newly established Joan and Sanford I. Weill Center for Metabolic Health at WCM.

Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.

Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.

Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.

Martin B. Leon, MD, Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Irving Medical Center, has been awarded the 2019 Lifetime Achievement Award by the American College of Cardiology (ACC) in honor of his contributions to the field of interventional cardiology.